Structure–activity relationships of cannabinoids: A joint CoMFA and pseudoreceptor modelling study

A cannabinoid pseudoreceptor model for the CB1-receptor has been constructed for 31 cannabinoids using the molecular modelling software YAK. Additionally, two CoMFA studies were performed on these ligands, the first of which was conducted prior to the building of the pseudoreceptor. Its pharmacophore is identical with the initial superposition of ligands used for pseudoreceptor construction. In contrast, the ligand alignment for the second CoMFA study was taken directly from the final cannabinoid pseudoreceptor model. This altered alignment gives markedly improved cross-validated r² values as compared to those obtained from the original alignment with values of 0.79 and 0.63, respectively, for five components. However, the pharmacophore alignment has the better predictive ability. Both the CoMFA and pseudoreceptor methods predict the free energy of binding of test ligands well.     

A New Ir‐NHC Catalyst for Signal Amplification by Reversible Exchange in D2O

NMR signal amplification by reversible exchange (SABRE) has been observed for pyridine, methyl nicotinate, N‐methylnicotinamide, and nicotinamide in D₂O with the new catalyst [Ir(Cl)(IDEG)(COD)] (IDEG=1,3‐bis(3,4,5‐tris(diethyleneglycol)benzyl)imidazole‐2‐ylidene). During the activation and hyperpolarization steps, exclusively D₂O was used, resulting in the first fully biocompatible SABRE system. Hyperpolarized ¹H substrate signals were observed at 42.5 MHz upon pressurizing the solution with parahydrogen at close to the Earth's magnetic field, at concentrations yielding barely detectable thermal signals. Moreover, 42‐, 26‐, 22‐, and 9‐fold enhancements were observed for nicotinamide, pyridine, methyl nicotinate, and N‐methylnicotinamide, respectively, in conventional 300 MHz studies. This research opens up new opportunities in a field in which SABRE has hitherto primarily been conducted in CD₃OD. This system uses simple hardware, leaves the substrate unaltered, and shows that SABRE is potentially suitable for clinical purposes.     

Characterization of the stereoselective biotransformation of ketamine to norketamine via determination of their enantiomers in equine plasma by capillary electrophoresis

A robust CE method for the simultaneous determination of the enantiomers of ketamine and norketamine in equine plasma is described. It is based upon liquid-liquid extraction of ketamine and norketamine at alkaline pH from 1 mL plasma followed by analysis of the reconstituted extract by CE in the presence of a pH 2.5 Tris-phosphate buffer containing 10 mg/mL highly sulfated beta-CD as chiral selector. Enantiomer plasma levels between 0.04 and 2.5 microg/mL are shown to provide linear calibration graphs. Intraday and interday precisions evaluated from peak area ratios (n = 5) at the lowest calibrator concentration are < 8 and < 14%, respectively. The LOD for all enantiomers is 0.01 microg/mL. After i.v. bolus administration of 2.2 mg/kg racemic ketamine, the assay is demonstrated to provide reliable data for plasma samples of ponies under isoflurane anesthesia, of ponies premedicated with xylazine, and of one horse that received romifidine, L-methadone, guaifenisine, and isoflurane. In animals not premedicated with xylazine, the ketamine N-demethylation is demonstrated to be enantioselective. The concentrations of the two ketamine enantiomers in plasma are equal whereas S-norketamine is found in a larger amount than R-norketamine. In the group receiving xylazine, data obtained do not reveal this stereoselectivity.     

RuCl3/CeCl3/NaIO4: a new bimetallic oxidation system for the mild and efficient dihydroxylation of unreactive olefins

[reaction: see text] The catalytic dihydroxylation of olefins represents a unique synthetic tool for the generation of two C,O-bonds with defined relative configuration. Whereas OsO(4) has been established as a very general dihydroxylation catalyst within the past 30 years, the less expensive and toxic isoelectronic RuO(4) has found only limited use for this type of oxygen-transfer reaction. High catalyst loading and undesired side reactions were severe drawbacks in RuO(4)-catalyzed oxidations of C,C-double bonds. Recently, we were able to improve the RuO(4)-catalyzed dihydroxylation by addition of Bronsted acids to the reaction mixture. This protocol proved to be of general applicability, however, certain limitations were observed. To address these problematic functional groups a new Lewis acid accelerated oxidation was developed. The use of only 10 mol % of CeCl(3) allowed a further decrease in the catalyst concentration down to 0.25 mol % while broadening the scope of the reaction. Silyl ethers and nitrogen containing functional groups are now tolerated in this optimized protocol. Furthermore, competing scission reactions are supressed in the presence of Lewis acid allowing longer reaction times and the successful oxidation of electron-deficient tetrasubstituted double bonds that cannot be oxidized using known dihydroxylation protocols.     

Synthesis of extended spacer-linked neooligodeoxysaccharides by metathesis olefination and evaluation of their RNA-binding properties

The preparation of linear 1,4-butanediol-linked oligodeoxysugars 50-53, 58 and 60 is described which are potential binders to polynucleotides. Various aminodeoxymonosaccharides 9, 13-18, 30, 31 and 40-42 which are either allylated at the anomeric center or at C4 were subjected to the metathesis olefination protocol. Depending on the position of allylation E/Z-mixtures of C₂-symmetric head-to-head or tail-to-tail homodimers were formed. Among them, saccharides 13, 30, 31 and 40 were transformed into the corresponding 1,4-butanediol linked disaccharides 50-53 by catalytic hydrogenation of the central olefinic double bond and exhaustive deprotection. In order to target extended spacer-linked neooligosaccharides homodimeric aminoglycoside 37 was bisallylated and subjected to cross metathesis conditions using methyl 4-O-allyl daunosamide 40 as reaction partner which yielded two desired trimeric and tetrameric linearly spacer-linked daunosamine derivatives. After hydrogenation and deprotection two additional probes 58 and 60 for nucleic acid binding studies were at hand.     

Vertex pancyclic in‐tournaments

An in‐tournament is an oriented graph such that the negative neighborhood of every vertex induces a tournament. The topic of this paper is to investigate vertex k‐pancyclicity of in‐tournaments of order n, where for some 3 ≤ k ≤ n, every vertex belongs to a cycle of length p for every k ≤ p ≤ n. We give sharp lower bounds for the minimum degree such that a strong in‐tournament is vertex k‐pancyclic for k ≤ 5 and k ≥ n − 3. In the latter case, we even show that the in‐tournaments in consideration are fully (n − 3)‐extendable which means that every vertex belongs to a cycle of length n − 3 and that the vertex set of every cycle of length at least n − 3 is contained in a cycle of length one greater. In accordance with these results, we state the conjecture that every strong in‐tournament of order n with minimum degree greater than is vertex k‐pancyclic for 5 < k < n − 3, and we present a family of examples showing that this bound would be best possible. © 2001 John Wiley & Sons, Inc. J Graph Theory 36: 84–104, 2001